Sen. Tammy Baldwin, D-Wis., told reporters Thursday that there’s a “prospect” for bipartisan support of a measure that she’s co-sponsoring that would cap what insured patients pay for insulin.
To access this content, you must purchase a Premium membership, or log in if you are a member.